调研速递|登康口腔接受长江证券等众多投资者调研,聚焦业务增长与竞争策略
Xin Lang Cai Jing·2025-09-25 14:15

Core Viewpoint - Chongqing Dengkang Oral Care Products Co., Ltd. held an online investor reception day and semi-annual performance briefing, addressing various investor inquiries regarding business development and market competition [1] Group 1: Business Development - The company is responding to structural changes in the consumer market by implementing a full-channel operational upgrade and constructing a "five-dimensional channel growth matrix" [1] - The company emphasizes a dual-driven strategy of "R&D + Marketing" to enhance its competitive edge in high-end toothpaste and electric toothbrushes [2] Group 2: Market Competition - Investors inquired about the differentiation advantages of the "Medical Research" series products compared to competitors, particularly in terms of technology patents and clinical endorsements [1] - The company plans to optimize its product mix and marketing strategies in response to market competition, particularly in the context of price wars [1] Group 3: Product Specifics - The "Medical Research 7 Days" toothpaste series will continue to penetrate channels and promote high-end product growth [2] - The company will introduce refined and advanced children's oral care products to address the decline in the children's category, leveraging the experience from the Medical Research series [2] - The company is committed to increasing R&D investment, particularly in the electric toothbrush category, which is a key focus for future growth [2]